Sarcopenic Obesity: Clinical Trials

2 trials for Sarcopenic Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Sarcopenic Obesity: new trials by email Literature Review of Sarcopenic Obesity trials Research Report on Sarcopenic Obesity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nutritional Strategies for Metabolic Health in Aging
Weight Loss and Weight Maintenance - Sarcopenic Obesity
Phase 1 / Phase 2TerminatedUniversity of Alaska Fairbanks62019-04-182022-04-14
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
Oxytocin nasal spray, Placebo nasal spray - Obesity, Sarcopenic Obesity
Phase 1 / Phase 2CompletedSara Espinoza232017-09-222021-10-22

Narrower conditions

Obesity (1)  ·  Sarcopenia (1)  ·  Sedentary Behavior (1)

Broader conditions

Atrophy (1)  ·  Behavior (1)  ·  Body Weight (1)  ·  Muscular Atrophy (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Sara Espinoza (1)  ·  University of Alaska Fairbanks (1)

Countries

United States (2)

Top investigators

Robert H Coker, PhD (1)  ·  Sara Espinoza, MD (1)

Results publications

PMID 34029521